CI Cigna Group
Hospital & Medical Service Plans · NYSE · SEC CIK 1739940 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.8%
TTM net income YoY-2.6%
TTM EPS YoY0.4%
Revenue 3-yr CAGR14.7%
Net income 3-yr CAGR4.0%
Margins
Gross margin—
Operating margin3.4%
Net margin2.1%
FCF margin—
EBITDA margin4.4%
Returns
ROE14.1%
ROA3.8%
ROIC (approx.)11.2%
Asset turnover1.81x
Leverage & solvency
Liabilities / assets72.3%
Debt / equity0.72x
Current ratio0.84x
Interest coverage7.12x
Cash quality & payout
Operating cash flow / net income1.57x
Accruals ratio-2.2%
Payout ratio27.2%
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY2022*2022-12-31 | FY2021*2021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $274.90B | $247.12B | $195.26B | $180.52B | $174.07B |
| Cost of revenue | $214.99B | $182.51B | $133.80B | $124.83B | $117.55B |
| SG&A expense | $14.62B | $14.84B | $14.82B | $13.17B | $13.01B |
| Operating income | $9.20B | $9.42B | $8.54B | $8.45B | $7.94B |
| Interest expense | $1.40B | $1.50B | $1.40B | $1.30B | $1.30B |
| Pretax income | $7.78B | $5.27B | $5.51B | $8.40B | $6.79B |
| Income tax | $1.49B | $1.49B | $141.00M | $1.61B | $1.37B |
| Net income | $5.96B | $3.43B | $5.16B | $6.70B | $5.37B |
| EBITDA | $11.97B | $12.19B | $11.57B | $11.39B | $10.86B |
| EPS (basic) | 22.33 | 12.25 | 17.57 | 21.66 | 15.89 |
| EPS (diluted) | 22.18 | 12.12 | 17.39 | 21.41 | 15.75 |
| Dividends declared per share | 6.04 | 5.60 | 4.92 | 4.48 | 4.00 |
| Weighted avg. shares (diluted) | 268.56M | 283.22M | 296.88M | 313.06M | 340.97M |
| Balance sheet | |||||
| Cash & equivalents | $7.68B | $7.55B | $7.87B | $5.98B | $5.12B |
| Short-term investments | $1.06B | $665.00M | $925.00M | $905.00M | $920.00M |
| Receivables | $28.77B | $24.23B | $17.72B | $17.22B | $15.07B |
| Inventory | $7.34B | $6.69B | $5.64B | $4.78B | $3.72B |
| Current assets | $47.81B | $48.87B | $37.35B | $30.12B | $36.13B |
| PP&E, net | $3.65B | $3.65B | $3.69B | $3.77B | $3.69B |
| Goodwill | $44.92B | $44.37B | $44.26B | $45.81B | $45.81B |
| Intangibles | $28.56B | $29.42B | $30.86B | $32.49B | $34.10B |
| Total assets | $157.92B | $155.88B | $152.76B | $143.88B | $154.89B |
| Current liabilities | $56.34B | $57.98B | $48.72B | $41.23B | $43.57B |
| Short-term debt | $592.00M | $3.04B | $2.77B | $2.99B | $2.54B |
| Long-term debt | $30.87B | $28.94B | $28.16B | $28.10B | $31.12B |
| Total debt | $31.46B | $31.97B | $30.93B | $31.09B | $33.67B |
| Total liabilities | $116.05B | $114.64B | $106.41B | $99.13B | $107.70B |
| Shareholders' equity | $41.71B | $41.03B | $46.22B | $44.67B | $47.11B |
| Net debt | $23.79B | $24.42B | $23.06B | $25.12B | $28.55B |
| Shares outstanding | 263.46M | 273.79M | 292.50M | 298.68M | 322.95M |
| Cash flow statement | |||||
| Operating cash flow | $9.60B | $10.36B | $11.81B | $8.66B | $7.19B |
| Investing cash flow | -$4.41B | -$2.10B | -$5.17B | $3.10B | -$3.61B |
| Financing cash flow | -$6.42B | -$7.65B | -$4.29B | -$11.24B | -$8.21B |
| Depreciation & amortization | $2.77B | $2.77B | $3.04B | $2.94B | $2.92B |
| Stock-based compensation | $291.00M | $308.00M | $286.00M | $264.00M | $268.00M |
| Dividends paid | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B |
| Share buybacks | $3.62B | $7.03B | $2.28B | $7.61B | $7.74B |
Free plan shows the latest 5 periods; Pro shows all 10 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.